3/n The paper takes 10 countries' worth of data, and compares their COVID-19 case numbers against the restrictions they had in place in early 2020, comparing those with less-restrictive non-pharmaceutical interventions (lrNPIs) with more-restrictive NPIs (mrNPIs)
4/n The basic findings are that, compared to South Korea and Sweden, the marginal impact of implementing mrNPIs was not possible to discern in this study
In other words, "lockdowns" don't have a significant marginal benefit over a suite of other measures
5/n This has actually been shown before, using much larger datasets and more rigorous (but still imperfect) analyses, so it's a bit odd that this particular paper has been seized on so much science.sciencemag.org/content/early/…
6/n I should also say I have something of an intellectual conflict of interest here, because the authors conclude something that I've been saying since March - the interventions pursued may be less important than the way that they are implemented
7/n All that being said, what's the science here
Well, it's a bit...lacklustre really
8/n The sample size is minuscule. 8 mrNPI and 2 lnNPI countries is far too few to make any realistic conclusions about much, especially given how wildly different these countries are
9/n The authors claim that they used these countries because those were the only ones where they could get data for each administrative region, but if that's the case then they really can't have looked very hard
10/n Off the top of my head, I can name at least half a dozen other countries for which case/policy data is available by day in every administrative region. Switzerland, Australia, New Zealand, China, Brazil, etc
11/n Indeed, going by the references that the authors cite, this issue may have arisen because they used Statista as their primary source for case data, which is...not ideal
12/n The definition of restrictions is also a bit weird. I mean, South Korea didn't forcibly close businesses, but they do have national legislation allowing practices that many countries would find very restrictive (as the references the authors cite show)
13/n There's also nothing in this paper about lags for any policy for implementation, how policies were associated with dates etc
That's a huge issue!
14/n We know that the lag between policy introduction, implementation, and outcome is not immediate, and this is likely to vary by country, so simply comparing them day-by-day as this paper appears to doesn't really give us any indication of their impact
15/n Furthermore, the lrNPIs themselves are really poorly elucidated. This is FAR from a fair summation of the complex and detailed work South Korea put in to controlling COVID-19!
16/n I mean, reading the paper you might get the impression that all South Korea did was some optional social distancing, emergency declaration, and case quarantine, rather than a coordinated and multi-step approach including HUGE healthcare investment
17/n There's also not much effort to disentangle the complexities of the marginal benefit of each intervention, unlike previous research. It's likely, for example, that closing schools in Sweden (that did little else) had a huge impact...
18/n ...but that this was not as effective as in Italy, which had many interventions
19/n The authors also use some fairly inappropriate causal language throughout. These are the potential benefits ASSOCIATED WITH the announcement of policies in each place, we certainly can't infer a causal impact here
20/n In other words, there are innumerable confounding factors that may have made the interventions more/less effective, like the age structure of the population, how socially distanced they were pre-pandemic etc...
21/n At best, this study provides us with some evidence that mrNPIs are not associated with a large marginal benefit in terms of case numbers over lnNPIs, when comparing a tiny group of dissimilar nations
22/n More realistically, I think we can probably say that the paper tells us little useful except that analysing the impact of NPIs generally is extremely hard
23/n This is a bit of a shame, because I actually agree wholeheartedly with the authors that there is a cost to restrictive NPIs, and the marginal benefit of (say) stay-at-home orders is likely to be quite small in many circumstances
24/n That being said, this paper just doesn't tell us anything useful about these mrNPIs beyond some more very vague evidence that they may not be as beneficial on top of other interventions (maybe)
25/n Ultimately, the authors may have failed to find a benefit of business closures or stay-at-home orders, but the methodology used just doesn't give us enough information to say much, if anything, conclusively
26/n Some more issues with the study, which gets worse and worse the more you look at it!
The final large published trial on ivermectin for COVID-19, PRINCIPLE, is now out. Main findings:
1. Clinically unimportant (~1-2day reduction) in time to resolution of symptoms. 2. No benefit for hospitalization/death.
Now, you may be asking "why does anyone care at all any more about ivermectin for COVID?" to which I would respond "yes"
We already knew pretty much everything this study shows. That being said, always good to have more data!
The study is here:
For me, the main finding is pretty simple - ivermectin didn't impact the likelihood of people going to hospital or dying from COVID-19. This has now been shown in every high-quality study out there.pubmed.ncbi.nlm.nih.gov/38431155/
What's particularly interesting is a finding that the authors don't really discuss in their conclusion. These results appear to show that gender affirming care is associated with a reduction in suicide risk 1/n
2/n The paper is a retrospective cohort study that compares young adults and some teens who were referred for gender related services in Finland with a cohort that was matched using age and sex. The median age in the study was 19, so the majority of the population are adults.
3/n The study is very limited. The authors had access to the Finnish registries which include a wide range of data, but chose to only correct their cohorts for age, sex, and number of psychiatric appointments prior to their inclusion in the cohort.
These headlines have to be some of the most ridiculous I've seen in a while
The study tested 18 different PFAS in a tiny sample of 176 people. Of those, one had a barely significant association with thyroid cancer
This is genuinely just not news at all
Here's the study. I'm somewhat surprised it even got published if I'm honest. A tiny case-control study, they looked at 88 people with thyroid cancer and 88 controls thelancet.com/journals/ebiom…
Here are the main results. There was a single measured PFAS which had a 'significant' association with the cancer, the others just look a bit like noise to me
A new study has gone viral for purportedly showing that running therapy had similar efficacy to medication for depression
Which is weird, because a) it's not a very good study and b) seems not to show that at all 1/n
2/n The study is here. The authors describe it as a "partially randomized patient preference design", which is a wildly misleading term. In practice, this is simply a cohort study, where ~90% of the patients self-selected into their preferred treatment sciencedirect.com/science/articl…
3/n This is a big problem, because it means that there are likely confounding factors between the two groups (i.e. who is likely to choose running therapy over meds?). Instead of a useful, randomized trial, this is a very small (n=141) non-randomized paper
The study showed that COVID-19 had, if anything, very few long-term issues for children! As a new father, I find this data very reassuring regarding #LongCovid in kids 1/n
2/n The study is here, it's a retrospective cohort comparing children aged 0-14 who had COVID-19 to a matched control using a database of primary care visits in Italy onlinelibrary.wiley.com/doi/10.1111/ap…
3/ The authors found that there was an increased risk of a range of diagnoses for the kids with COVID-19 after their acute disease, including things like runny noses, anxiety/depression, diarrhoea, etc
This study has recently gone viral, with people saying that it shows that nearly 20% of highly vaccinated people get Long COVID
I don't think it's reasonable to draw these conclusions based on this research. Let's talk about bias 1/n
2/n The study is here. It is a survey of people who tested positive to COVID-19 in Western Australia from July-Aug 2022 medrxiv.org/content/10.110…
3/n This immediately gives us our first source of bias
We KNOW that most cases of COVID-19 were missed at this point in the pandemic, so we're only getting the sample of those people who were sick enough to go and get tested